Growth Metrics

Soleno Therapeutics (SLNO) Non Operating Income: 2013-2024

Historic Non Operating Income for Soleno Therapeutics (SLNO) over the last 9 years, with Dec 2024 value amounting to $11.8 million.

  • Soleno Therapeutics' Non Operating Income fell 257.96% to -$650,000 in Q4 2017 from the same period last year, while for Dec 2017 it was -$1.3 million, marking a year-over-year decrease of 179.21%. This contributed to the annual value of $11.8 million for FY2024, which is 393.36% up from last year.
  • Soleno Therapeutics' Non Operating Income amounted to $11.8 million in FY2024, which was up 393.36% from $2.4 million recorded in FY2023.
  • In the past 5 years, Soleno Therapeutics' Non Operating Income ranged from a high of $11.8 million in FY2024 and a low of $330,000 during FY2022.
  • Its 3-year average for Non Operating Income is $4.8 million, with a median of $2.4 million in 2023.
  • Data for Soleno Therapeutics' Non Operating Income shows a peak YoY soared of 626.06% (in 2023) over the last 5 years.
  • Yearly analysis of 3 years shows Soleno Therapeutics' Non Operating Income stood at $330,000 in 2022, then surged by 626.06% to $2.4 million in 2023, then surged by 393.36% to $11.8 million in 2024.